Literature DB >> 33337922

Glycans: potential therapeutic targets for cholangiocarcinoma and their therapeutic and diagnostic implications.

Atit Silsirivanit1,2,3.   

Abstract

Entities:  

Keywords:  Bile ducts; biomarker; cancer; glycan; glycosylation; liver; targeted therapy

Year:  2020        PMID： 33337922     DOI： 10.1080/14728222.2021.1861250

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN： 1472-8222            Impact factor:   6.902


× No keyword cloud information.
  2 in total

1.  Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways.

Authors:  Juthamas Khiaowichit; Chutima Talabnin; Chavaboon Dechsukhum; Atit Silsirivanit; Krajang Talabnin
Journal:  Life (Basel)       Date:  2022-01-25

2.  A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by Butea monosperma Agglutinin.

Authors:  Karuntarat Teeravirote; Sukanya Luang; Sakda Waraasawapati; Patcharee Boonsiri; Chaisiri Wongkham; Sopit Wongkham; Atit Silsirivanit
Journal:  Molecules       Date:  2021-05-08       Impact factor: 4.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.